JP2017514874A5 - - Google Patents

Download PDF

Info

Publication number
JP2017514874A5
JP2017514874A5 JP2016566933A JP2016566933A JP2017514874A5 JP 2017514874 A5 JP2017514874 A5 JP 2017514874A5 JP 2016566933 A JP2016566933 A JP 2016566933A JP 2016566933 A JP2016566933 A JP 2016566933A JP 2017514874 A5 JP2017514874 A5 JP 2017514874A5
Authority
JP
Japan
Prior art keywords
composition
intended
use according
composition intended
pufa
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016566933A
Other languages
English (en)
Japanese (ja)
Other versions
JP6819957B2 (ja
JP2017514874A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2015/029790 external-priority patent/WO2015171960A1/en
Publication of JP2017514874A publication Critical patent/JP2017514874A/ja
Publication of JP2017514874A5 publication Critical patent/JP2017514874A5/ja
Application granted granted Critical
Publication of JP6819957B2 publication Critical patent/JP6819957B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016566933A 2014-05-08 2015-05-07 10−ヒドロキシ−2−デセン酸を含む方法及び組成物 Expired - Fee Related JP6819957B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201461990283P 2014-05-08 2014-05-08
US61/990,283 2014-05-08
PCT/US2015/029790 WO2015171960A1 (en) 2014-05-08 2015-05-07 Methods and compositions comprising 10-hydroxy-2-decenoic acid

Publications (3)

Publication Number Publication Date
JP2017514874A JP2017514874A (ja) 2017-06-08
JP2017514874A5 true JP2017514874A5 (enExample) 2018-03-15
JP6819957B2 JP6819957B2 (ja) 2021-01-27

Family

ID=54393026

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016566933A Expired - Fee Related JP6819957B2 (ja) 2014-05-08 2015-05-07 10−ヒドロキシ−2−デセン酸を含む方法及び組成物

Country Status (8)

Country Link
US (1) US10004711B2 (enExample)
EP (1) EP3139741A4 (enExample)
JP (1) JP6819957B2 (enExample)
KR (1) KR102399290B1 (enExample)
CN (1) CN106470547B (enExample)
BR (1) BR112016026143A2 (enExample)
TW (1) TWI743022B (enExample)
WO (1) WO2015171960A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11197840B2 (en) * 2015-12-04 2021-12-14 Wah Chin BOON Methods of treating or alleviating mental disorders and associated symptoms
WO2019195658A1 (en) 2018-04-05 2019-10-10 Dana-Farber Cancer Institute, Inc. Sting levels as a biomarker for cancer immunotherapy
CN108310026A (zh) * 2018-04-28 2018-07-24 宁夏医科大学 月见草油在改善多囊卵巢综合征慢性炎症方面的应用
JP7240714B2 (ja) * 2019-01-24 2023-03-16 株式会社山田養蜂場本社 γヒドロキシ酪酸受容体結合剤
CN110916088A (zh) * 2019-11-04 2020-03-27 齐鲁工业大学 一种适合炎性肠病人群的全营养特医食品及制备方法
CN112094790B (zh) * 2020-11-17 2021-03-02 河北一然生物科技有限公司 一种调节肠道菌群的植物乳杆菌lp45活菌制剂及应用
TWI793922B (zh) * 2021-12-14 2023-02-21 彥臣生技藥品股份有限公司 一種用於提升認知能力之組合物及其用途
CN116570582A (zh) * 2023-05-19 2023-08-11 中国药科大学 10-羟基癸烯酸在制备重度抑郁治疗药物中的应用
CN119745857A (zh) * 2024-12-02 2025-04-04 温州医科大学 10-羟基-2-癸烯酸在药物制备中的应用

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1033843A (en) 1964-05-26 1966-06-22 Eustace Cecil Barton Wright Pharmaceutical composition for treating thermatoid arthritis
GB1145623A (en) 1966-03-09 1969-03-19 Eustace Cecil Barton Wright Pharmaceutical composition
JPH10114652A (ja) 1996-10-15 1998-05-06 Dokutaazu Kosumeteikusu:Kk 津液改善剤及びそれを含有する経口投与用組成物
AU7222598A (en) * 1997-04-29 1998-11-24 Scotia Holdings Plc Treatment of depression and anxiety using docosahexaenoic acid or natural antioxidants
FR2773484B1 (fr) * 1998-01-09 2001-03-30 Pierre Moreau Nouvelles compositions a effet synergique entre micronutriments et substances d'origine vivante
DE19844022C1 (de) 1998-09-25 2000-05-25 Sherif Sabry Ragab Mekkawi Verwendung von eisenbindenden Glycoproteinen und/oder 10-Hydroxy-2-decensäure in Verbindung mit Thymochinon zur Behandlung von AIDS
WO2001091575A1 (en) * 2000-06-01 2001-12-06 United Feeds, Inc. Animal food and method
FR2825919B1 (fr) * 2001-06-14 2004-06-11 Oreal Utilisation d'au moins un derive de l'acide 10-hydroxy-2- decenoique dans des compositions destinees a traiter les signes cutanes du vieillissement
FR2829491B1 (fr) 2001-09-12 2005-09-30 Diverchim Procede de preparation des hydroxy-acides gras insatures et de leurs esters, leur utilisation comme agent anti-collagenase
JP2005519939A (ja) * 2002-03-08 2005-07-07 モンサント テクノロジー エルエルシー 炎症性疾患の治療および予防
KR20050057127A (ko) 2002-09-06 2005-06-16 하야시바라 겐 정제 로얄 젤리
JP2004131407A (ja) * 2002-10-09 2004-04-30 Yamada Bee Farm ローヤルゼリー又はその水溶性画分を有効成分とする抗うつ性組成物
JP4657778B2 (ja) 2004-03-30 2011-03-23 曽田香料株式会社 アラキドン酸代謝抑制剤
JP4727939B2 (ja) 2004-03-31 2011-07-20 アピ株式会社 低アレルゲン化ローヤルゼリーの製造方法
JP4579620B2 (ja) * 2004-08-25 2010-11-10 アピ株式会社 エストロゲン様作用剤及びその製造方法、並びに骨粗しょう症予防剤及び骨粗しょう症治療剤
CN1836671A (zh) 2005-03-21 2006-09-27 通化盛和药业股份有限公司 一种中药软胶囊及其制备方法和质量控制方法
FR2892410B1 (fr) 2005-10-21 2010-10-15 Fabre Pierre Dermo Cosmetique Nouveaux hydro-acides gras insatures et leur utilisation dermo cosmetologique
CA2632934A1 (en) * 2005-12-20 2007-07-05 Novozymes Biologicals, Inc. Surfactants systems for surface cleaning
CN101370490A (zh) * 2005-12-29 2009-02-18 希尔氏宠物营养品公司 用于预防或治疗炎症性肠病的组合物及其制备方法
WO2007130581A2 (en) 2006-05-04 2007-11-15 Hardwicke Susan B Compositions and methods for psychiatric conditions and cognition enhancement
JP4749366B2 (ja) 2007-03-23 2011-08-17 株式会社山田養蜂場本社 ローヤルゼリー粉末からなる錠剤およびその製造方法
JPWO2009014105A1 (ja) 2007-07-20 2010-10-07 株式会社山田養蜂場本社 新規カルボン酸およびそれを有効成分とする抗うつ用組成物
JP2009274961A (ja) 2008-05-12 2009-11-26 Api Co Ltd 吸収促進剤
WO2009154197A1 (ja) * 2008-06-17 2009-12-23 ジャパンローヤルゼリー株式会社 認知障害改善剤
JP2010111646A (ja) * 2008-11-07 2010-05-20 Hayashibara Biochem Lab Inc 潰瘍性大腸炎治療剤
JP2010260833A (ja) * 2009-05-11 2010-11-18 Daicho Kikaku:Kk 抗自己免疫疾患剤
CN101570482B (zh) 2009-06-09 2012-12-26 李应阳 由ω-氯辛醇合成蜂王酸的方法
JP2012031153A (ja) * 2010-06-29 2012-02-16 Takara Bio Inc 脂肪燃焼促進剤
JP5770453B2 (ja) 2010-11-22 2015-08-26 八幡物産株式会社 ローヤルゼリー含有組成物及びソフトカプセル
JP5923699B2 (ja) * 2011-03-30 2016-05-25 アピ株式会社 老化防止剤
EP2726086A4 (en) * 2011-06-30 2015-04-29 Nitromega Corp COMPOSITIONS WITH NITRO FATTY ACIDS
CN102408395B (zh) 2011-10-24 2014-04-02 广西师范大学 新的哌嗪和高哌嗪类衍生物及其制备方法和应用
WO2013066152A1 (en) * 2011-10-31 2013-05-10 N.V. Nutricia Method for improving executive function
EP2822403B1 (en) * 2012-03-07 2022-05-04 Children's Medical Center Corporation Methods and uses for enhancing, improving, or increasing fertility or reproductive function
CN104427887A (zh) * 2012-03-14 2015-03-18 雅培制药有限公司 包含RRR-α生育酚和多不饱和脂肪酸的营养组合物
US20140271844A1 (en) * 2013-03-15 2014-09-18 Nitromega Corp. Compositions containing nitro fatty acids

Similar Documents

Publication Publication Date Title
JP2017514874A5 (enExample)
Devassy et al. Omega-3 polyunsaturated fatty acids and oxylipins in neuroinflammation and management of Alzheimer disease
Bhaswant et al. Mechanisms of enhanced insulin secretion and sensitivity with n-3 unsaturated fatty acids
CU20140151A7 (es) Composición farmacéutica útil en la prevención de un evento cardiovascular mayor
MX356427B (es) Emulsion que contiene hormona.
JP2016512245A5 (ja) マイボーム腺を標的とする組成物
MY165048A (en) Dpa-enriched compositions of omega-3 polyunsaturated fatty acids in free acid form
AR103371A1 (es) Composiciones y métodos para diagnosis y tratamiento de síndrome metabólico, uso
UA109528C2 (uk) Поліненасичені жирні кислоти для лікування захворювань, які належать до ряду серцево-судинних, метаболічних та запальних захворювань
JP2015527386A5 (enExample)
JP2014090695A5 (enExample)
CY1122248T1 (el) Μιγμα λιπαρων οξεων προς χρηση στη θεραπευτικη αγωγη φλεγμονωδων παθολογιων
HRP20160203T1 (hr) Pripravci koji sadrže 15-hepe i postupci njihove upotrebe
HK1198515A1 (en) Fatty acid compositions
WO2016027216A3 (en) A synergistic edible oil composition
WO2016040570A3 (en) Dietary emulsion formulations and methods for using the same
JP2017505809A5 (enExample)
WO2014165190A3 (en) Compositions comprising docosapentaenoic acid and methods of use
EP3886907C0 (en) SEMI-FLUORINATED ALKANE COMPOSITIONS COMPRISING ETHYL ESTERS OF OMEGA-3 FATTY ACIDS
JP2013532984A5 (enExample)
BR112017007428A2 (pt) composições de éster de ácido graxo e ácidos graxos autocomnizantes e suas utilizações no tratamento de estados da doença
JP2012143228A5 (enExample)
MA40417A (fr) Mélange d'acides gras et de palmitoyl éthanolamide pour utilisation dans le traitement de pathologies inflammatoires et allergiques
BR112018001164A2 (pt) composto de fórmula geral, composição farmacêutica e método para o tratamento de uma doença cardiovascular
JP2016501248A5 (enExample)